Email Updates

You are here

Home

26 MAY 2023 VOLUME 25 ISSUE 21

Media Coverage

  • African Countries Are Making the Transition From Donor-Funded HIV Programmes to Government-Led Initiatives

    "We, as Africans, are the agenda and have the capacity to lead the HIV response. We need to create our own funding bill. Africans and its leaders have a role to play in conceptualising ideas and solutions," Yvette Raphael from the Advocates for the Prevention of HIV in Africa told the recent INTEREST conference in Maputo, Mozambique.

    May 25, 2023
    General
    aidsmap

  • HIV Prevention Highlights To Look Out For At IAS 2023

    IAS 2023, the 12th IAS Conference on HIV Science, will feature the latest science on HIV prevention – from voluntary medical male circumcision to PrEP access among trans women and men who have sex with men. Register for IAS 2023 today and join thousands of HIV professionals in Brisbane, Australia, and virtually from 23 to 26 July 2023.

    May 25, 2023
    General
    POZ Magazine

  • Monkey Model Offers Clues for Potential Widespread HIV Cure in People

    New animal research is helping explain why at least five people have become HIV-free after receiving a stem cell transplant. The study's insights may bring scientists closer to developing what they hope will become a widespread cure for the virus that causes AIDS, which has infected about 38 million people worldwide.

    May 25, 2023
    Cure
    Medical Xpress

  • Navigating Mpox: How to Prepare for Pride Season

    A little over a year ago, on May 17, 2022, Americans learned that another pathogen had entered the population just as they were recovering from the COVID-19 pandemic. Earlier that day, mpox, formerly known as monkeypox, was confirmed in Massachusetts after spreading throughout Europe. Since then, 30,395 cases have been registered in the United States, and while the number of cases is down significantly, health officials warn that it will take work to keep mpox at bay. Now a recent cluster of cases in Illinois demonstrates the need for vigilance.

    May 25, 2023
    General
    Advocate

  • First-in-Human Nanoparticle HIV Vaccine Induces Broad and Publicly Targeted Helper T Cell Responses

    Researchers from Fred Hutchinson Cancer Center in Seattle, Scripps Research in La Jolla, California, IAVI and other collaborating institutions have characterized robust T-cell responses in volunteers participating in the IAVI G001 Phase 1 clinical trial to test the safety and immune response of a self-assembling nanoparticle HIV vaccine.

    May 25, 2023
    HIV Vaccine
    News Medical

  • To Prevent a Resurgence of Mpox: Vaccinate

    Vaccination is still a cornerstone of the effort to end the mpox outbreak in the United States, which has resulted in more than 30,000 reported cases in this country, according to public health officials. “The outbreak is not over, and we need to remain alert and continue our prevention efforts,” said Christopher R. Braden, MD, the CDC mpox response incident manager, during a press briefing.

    May 24, 2023
    General
    Infectious Disease Special Edition

  • Hepatitis C Virus Disproportionately Affects Immigrants, Study Finds

    Rates of hepatitis C virus (HCV) infection were 10 percent higher among immigrants in Canada than nonimmigrants, with refugees accounting for 30 percent of all diagnoses, according to a recent study that could help develop targeted screening for the disease. The population-based, retrospective cohort study, published in Journal of Viral Hepatitis, examined trends in newly reported HCV diagnoses. It included 38,348 individuals, recruited in Quebec, Canada between January 1998-December 2018.

    May 24, 2023
    General
    Contagion Live

  • Money, Sex and Rumors: Tanzania Faces Challenges to Protect Girls From HPV

    When the health workers arrived at Upendo Primary School on the edge of Dar es Salaam, Tanzania, they instructed girls who would turn 14 this year to line up to get a shot. Quinn Chengo held an urgent, whispered consultation with her friends. What was the injection for, really? Could it be a COVID-19 vaccine? (They had heard rumors about that.) Or was it meant to keep them from having babies?

    May 23, 2023
    HPV Vaccines
    New York Times

  • Parents’ Mistrust of HPV Vaccine May Be Growing

    It was a no-brainer for New York City mom Jen L. when a pediatrician suggested that she vaccinate her two sons against human papillomavirus (HPV). "Before my kids were eligible for the vaccine, I had read up on it to learn about the vaccine and its positives in general, and also to learn if there were any significant side effects," she said. "I have a good friend who had issues from HPV in her 20s, and I was excited to read a vaccine could now help prevent all the drama she had gone through."

    May 23, 2023
    HPV Vaccines
    Medical Xpress

  • HIV Infections Drop, But Racial Gaps Remain

    Data from the Centers for Disease Control and Prevention released Tuesday shows a significant drop in new HIV infections across the US — a 12 percent decrease between 2017 and 2021. Young people accounted for the bulk of the progress during that period, with new infections dropping 34 percent among 13- to 24-year-olds.

    May 23, 2023
    General
    Politico

  • HIV Rates Decline in US, Data Show, But Disparities Persist

    The latest accounting of HIV incidence in the United States is a mixed bag. Overall estimated new infections dropped 12 percent in 2021 compared to 2017, according to data released Tuesday by the Centers for Disease Control and Prevention. But the American South — which has had a longtime HIV problem compared with other areas across the US — was the only region to show a “statistically significant decline.”

    May 23, 2023
    General
    STAT

  • New Studies for Longtime HIV Therapy Reinforce Efficacy, Safety Profile

    Two phase 3 studies provide long term data demonstrating the sustained efficacy and clinical safety of B/F/TAF. Specifically, the Week 240 results reinforce the antiretroviral’s role as a guidelines recommended treatment option for a broad range of people with HIV and demonstrated the sustained efficacy and durable viral suppression. The data support the long-term use of Biktarvy, with no significant changes to metabolic, bone, and renal health markers through five years.

    May 23, 2023
    Treatment
    Contagion Live

  • New Policies Aim To Integrate Mental Health Support Into HIV Services

    Research suggests that people living with HIV are more likely to have mental health conditions than the general population. There seems to be consensus that HIV programmes would benefit from including better mental health screening and support services. Two new policy documents – the Mental Health Policy Framework and the National Strategic Plan for HIV, TB and STIs – have a lot to say about providing such integrated services, but will they result in actual changes on the ground?

    May 23, 2023
    General
    Daily Maverick

  • Community Support for Caregivers Helps Children Living With HIV Achieve Viral Suppression

    Children living with HIV are less likely to achieve sustained viral load suppression if their caregivers are younger, if their caregivers are not virally suppressed or if the children are on a protease inhibitor-based regimen, the recent INTEREST 2023 conference in Maputo, Mozambique, heard.

    May 22, 2023
    General
    aidsmap

  • A New Approach to Curbing Sexually Transmitted Infections Gains Interest

    Research shows taking a certain antibiotic after sex can significantly reduce the risk of getting sexually transmitted infections. It is seen as a promising approach to curb the nation's STI epidemic.

    May 22, 2023
    General
    NPR

  • Real-World Assessment of JYNNEOS Vaccine Effectiveness During the 2022 Mpox Outbreak in the US

    A recent study published in Morbidity and Mortality Weekly Report estimated the efficacy of the JYNNEOS vaccine against mpox.

    May 22, 2023
    General
    News Medical

  • How a Breakthrough Treatment Helped ‘Cure’ This Man of HIV

    Paul Edmonds says that if you were to step back in time to tell his 1988 self (newly diagnosed with not just HIV, but AIDS) that today he would be living with his HIV in remission, now no longer detectable at all, “I don’t know if I would have believed it. It was a different world back then.”

    May 22, 2023
    Cure
    Healthline

  • ‘Our Stories Told by Us’ Unearths the Buried Stories of the UK’s HIV Movement

    “We could have just sat down and accepted other people writing our stories,” Angelina Namiba tells me over a cup of tea. “But we said no. We have voices. We can speak out. So we’ll do it for ourselves!” Angelina, a legend in global HIV efforts, is talking about Our Stories Told by Us: Celebrating the African Contribution to the UK HIV Response, a new book―out at the end of May 2023―that’s already causing a frenzy of excitement.

    May 22, 2023
    General
    TheBody

  • HIV Testing Is Changing in South Africa – Here’s Why It’s a Good Thing

    South Africa has been using HIV rapid diagnostic tests (fingerprick, same-day testing) for years. Now, the Health Department has decided to align with the World Health Organization’s recommendation of a new three-test algorithm to ensure accuracy of results. René Sparks unpacks why this is important.

    May 21, 2023
    General
    Daily Maverick

  • In Their Own Words: An Early Epidemic History

    I am looking forward to speaking with Richard Berkowitz and Helen Schietinger on Thursday, June 1, at 3 pm EST about the earliest days of the HIV/AIDS epidemic. They are two amazing activists and amongst the dwindling few who can speak first-hand to what happened in those critical first years. Join us to learn about those early days. “in their own words”.

    May 20, 2023
    General
    POZ Magazine

Published Research

Announcements